Efficacy and safety of vascular-targeting agents plus chemotherapy versus chemotherapy alone in recurrent or metastatic nasopharyngeal carcinoma patients:A multicenter observational clinical trial

Guanhong Luo, Guanjie Qin, Yixin Su, Yufei Pan, Jianxun Lu, Yueyun Xie, Bin Zhang, Jinxuan Dai, Xiangyun Kong, Yuan Xie, Xiaolan Ruan, Yunyan Mo, Ruyun Zhang, Wei Jiang

Open source

DOI
10.21203/rs.3.rs-4065562/v1
Published
2024-03-29
Container
Not recorded
Publisher
Research Square Platform LLC
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-4065562/v1,
  title = {Efficacy and safety of vascular-targeting agents plus chemotherapy versus chemotherapy alone in recurrent or metastatic nasopharyngeal carcinoma patients:A multicenter observational clinical trial},
  author = {Guanhong Luo and Guanjie Qin and Yixin Su and Yufei Pan and Jianxun Lu and Yueyun Xie and Bin Zhang and Jinxuan Dai and Xiangyun Kong and Yuan Xie and Xiaolan Ruan and Yunyan Mo and Ruyun Zhang and Wei Jiang},
  year = {2024},
  doi = {10.21203/rs.3.rs-4065562/v1},
  url = {https://doi.org/10.21203/rs.3.rs-4065562/v1}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of vascular-targeting agents plus chemotherapy versus chemotherapy alone in recurrent or metastatic nasopharyngeal carcinoma patients:A multicenter observational clinical trial
AU  - Guanhong Luo
AU  - Guanjie Qin
AU  - Yixin Su
AU  - Yufei Pan
AU  - Jianxun Lu
AU  - Yueyun Xie
AU  - Bin Zhang
AU  - Jinxuan Dai
AU  - Xiangyun Kong
AU  - Yuan Xie
AU  - Xiaolan Ruan
AU  - Yunyan Mo
AU  - Ruyun Zhang
AU  - Wei Jiang
PY  - 2024
DO  - 10.21203/rs.3.rs-4065562/v1
UR  - https://doi.org/10.21203/rs.3.rs-4065562/v1
ER  - 

APA

Luo, G., Qin, G., Su, Y., Pan, Y., Lu, J., Xie, Y., Zhang, B., Dai, J., Kong, X., Xie, Y., Ruan, X., Mo, Y., Zhang, R., & Jiang, W. (2024). Efficacy and safety of vascular-targeting agents plus chemotherapy versus chemotherapy alone in recurrent or metastatic nasopharyngeal carcinoma patients:A multicenter observational clinical trial. https://doi.org/10.21203/rs.3.rs-4065562/v1

Source records